News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Elastagen Stretches Commercial Wings
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
New Sydney University spinoff Elastagen is courting potential investors and commercial collaborators to develop organ-and-tissue-engineering applications for its super-stretchy protein, tropoelastin.
Twitter
LinkedIn
Facebook
Email
Print
Startups
Australia
MORE ON THIS TOPIC
C-suite
UPDATED: With Novo CEO’s Sudden Exit, Analysts Worry ‘There’s Something Pretty Wrong Here’
May 16, 2025
·
5 min read
·
Annalee Armstrong
Deals
Bluebird’s Private Equity Buyout Boosts Upfront Cash for Shareholders
May 15, 2025
·
1 min read
Manufacturing
Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment
May 15, 2025
·
2 min read
·
Tristan Manalac
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
·
2 min read
·
Dan Samorodnitsky
